Carboplatin/trastuzumabAcquired drug resistance: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1785卷 / 1期

关键词：

D O I：

10.1007/s40278-020-73119-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：138 / 138

相关论文

共 50 条

[1] TrastuzumabAcquired resistance: case report
Reactions Weekly, 2021, 1860 (1) : 338 - 338
[2] Pertuzumab/trastuzumabAcquired resistance: case report
Reactions Weekly, 2023, 1945 (1) : 442 - 442
[3] Pertuzumab/trastuzumabAcquired drug resistance: 3 case reports
Reactions Weekly, 2019, 1778 (1) : 377 - 377
[4] Carboplatin/Pembrolizumab/PemetrexedAcquired drug resistance: case report
Reactions Weekly, 2024, 2030 (1) : 119 - 119
[5] Cabazitaxel/carboplatin/enzalutamideDevelopment of drug resistance: case report
Reactions Weekly, 2020, 1800 (1) : 89 - 89
[6] Carboplatin/entrectinib/paclitaxelLack of efficacy and drug resistance: case report
Reactions Weekly, 2022, 1901 (1) : 148 - 148
[7] Carboplatin/osimertinib/pemetrexedNephrotoxicity and acquired drug resistance: case report
Reactions Weekly, 2021, 1879 (1) : 89 - 89
[8] Carboplatin/osimertinib/pemetrexedFever, diarrhoea and drug resistance: case report
Reactions Weekly, 2023, 1970 (1) : 87 - 87
[9] Carboplatin/gemcitabine/osimertinibAcquired drug resistance and lack of efficacy: case report
Reactions Weekly, 2022, 1930 (1) : 158 - 158
[10] Carboplatin/gefitinib/vinorelbineDevelopment of drug resistance and lack of efficacy: case report
Reactions Weekly, 2023, 1944 (1) : 183 - 183

← 1 2 3 4 5 →